microRNA

You have access
Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells
JUNKO MUKOHYAMA, MINORI KOIZUMI, KIMIHIRO YAMASHITA, AKIHIDE YOSHIMI, DAI SHIDA and YOSHIHIRO KAKEJI

Anticancer Research August 2024, 44 (8) 3553-3556; DOI: https://doi.org/10.21873/anticanres.17177
You have access
Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer
WERONIKA ŚWITLIK, ZBIGNIEW WYŻEWSKI, KAROLINA GREGORCZYK-ZBOROCH, MARTA GIETLER, AGNIESZKA PUDLARZ, JOANNA SZEWIŃSKA, SŁAWOMIR ORZECHOWSKI, SŁAWOMIR JAKIEŁA and JANUSZ SZEMRAJ

Anticancer Research June 2024, 44 (6) 2445-2451; DOI: https://doi.org/10.21873/anticanres.17051
You have access
Antitumor Effect of Galectin-9 on Cell Proliferation and Tumor Growth of Human Duodenal Adenocarcinoma Cells
TOSHIAKI KONO, SHINTARO FUJIHARA, KYOKO OURA, HISAKAZU IWAMA, KOJI FUJITA, NAOKI FUJITA, KEI TAKUMA, MASAHIRO ONO, DAISUKE NAMIMA, HIROKI YAMANA, TAIGA CHIYO, KIYOYUKI KOBAYASHI, HIDEKI KAMADA, HIDEKI KOBARA, MASAHUMI ONO, TOSHIRO NIKI, MITSUOMI HIRASHIMA and TSUTOMU MASAKI

Anticancer Research August 2023, 43 (8) 3769-3777; DOI: https://doi.org/10.21873/anticanres.16562
You have access
Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma
MAHYAR SHARIF BAGHERI, JIRI POLIVKA, INKA TRESKOVA, KATERINA HOUFKOVA, TEREZA KNIZKOVA, VLASTIMIL WOZNICA, TOMAS FIKRLE, KRISTYNA PIVOVARCIKOVA, MARTIN SVATON, DATTATRYA SHETTI, RASHMI NEGI and MARTIN PESTA

Anticancer Research February 2023, 43 (2) 695-706; DOI: https://doi.org/10.21873/anticanres.16208
You have access
Screening for Ovarian Cancer in the General Population: State of Art and Perspectives of Clinical Research
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research September 2022, 42 (9) 4207-4216; DOI: https://doi.org/10.21873/anticanres.15921
You have access
Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells
SEUNG WAN SON, SEUNG HYEOK HEO, SANG SU OH, CHAN HEE LEE and JONG KOOK PARK

Anticancer Research September 2022, 42 (9) 4265-4272; DOI: https://doi.org/10.21873/anticanres.15926
You have access
Effect of Aspirin on G₀/G₁ Cell Cycle Arrest and microRNA Signatures in Pancreatic Adenocarcinoma Cells
RYOTA NAKABAYASHI, SHINTARO FUJIHARA, HISAKAZU IWAMA, SAE HAMAYA, TAKAAKI MIZUO, MASAHIRO HIRATA, KOJI FUJITA, TOSHIAKI KONO, DAISUKE NAMIMA, NAOKI FUJITA, HIROKI YAMANA, KIYOYUKI KOBAYASHI, HIDEKI KAMADA, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, KEIICHI OKANO and TSUTOMU MASAKI

Anticancer Research August 2022, 42 (8) 4037-4048; DOI: https://doi.org/10.21873/anticanres.15900
You have access
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO and TSUTOMU MASAKI

Anticancer Research March 2022, 42 (3) 1263-1275; DOI: https://doi.org/10.21873/anticanres.15593
You have access
Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma
PRAMOD NEPAL, YUTO HOZAKA, TAKAKO TANAKA, MASUMI WADA, SHUNICHI ASAI, CHIKASHI MINEMURA, TETSUYA IDICHI, TAKAAKI ARIGAMI, HIROSHI KURAHARA, NAOHIKO SEKI and TAKAO OHTSUKA

Anticancer Research October 2021, 41 (10) 4821-4836; DOI: https://doi.org/10.21873/anticanres.15297
You have access
miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A)
NOBUYUKI MARUYAMA, MASATO UMIKAWA, HIROFUMI MATSUMOTO, TESSHO MARUYAMA, KAZUHIDE NISHIHARA, TOSHIYUKI NAKASONE, AKIRA MATAYOSHI, TAKAHIRO GOTO, FUSAHIRO HIRANO, AKIRA ARASAKI, HIROYUKI NAKAMURA, GORO MATSUZAKI and GIICHI TAKAESU

Anticancer Research November 2020, 40 (11) 6101-6113; DOI: https://doi.org/10.21873/anticanres.14631

Main menu

User menu

Search

microRNA

Pages